Stay updated on Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedA Publications section was added, including a citation for a Stem Cell Research Therapy article and a note that PubMed-fetched publications are auto-filled for the study. This information provides reference material but does not alter the trial protocol, endpoints, or eligibility.SummaryDifference0.3%

- Check14 days agoChange DetectedA minor version update (Revision: v3.3.2) is shown replacing the previous revision (v3.3.1) with no changes to core content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision history updated: added Revision v3.3.1 and removed Revision v3.2.0. This update affects administrative records and does not alter study content.SummaryDifference0.1%

- Check29 days agoChange DetectedThe notice about lapse in government funding and operating status has been removed from the page, while all study-related information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows only cosmetic layout adjustments with no changes to core study details (title, eligibility, endpoints, locations).SummaryDifference0.4%

- Check72 days agoChange DetectedThe page now communicates a funding-related operating-status notice and that the NIH Clinical Center is open, along with a version upgrade to v3.2.0, replacing v3.1.0.SummaryDifference3%

Stay in the know with updates to Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.